BioCentury Article Highlights GNS Discoveries on Behalf of The MMRF

GNS Healthcare Inc. (Cambridge, Mass.) said it has identified four genes as “top drivers” of high-risk multiple myeloma. Using its machine learning technology, the company is collaborating with the Multiple Myeloma Research Foundation (MMRF) to analyze data in the foundation’s patient-driven, real-world CoMMpass study. Read the full story here.

PharmiWeb.com: New Data at ASH 2015 from the Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation (MMRF) is presenting today new data from the MMRF CoMMpass StudySM – the most comprehensive long-term genomic study ever conducted in myeloma and one that may significantly advance the understanding of multiple myeloma. The data provide significant insights into the genetics of multiple myeloma and the potential association to patient […]

The Multiple Myeloma Research Foundation and GNS Healthcare Uncover Novel Drivers of Clinical Outcomes in Multiple Myeloma

Results of Big Data and Machine Learning Collaboration Featured at American Society of Hematology Annual Meeting NORWALK, Conn. and CAMBRIDGE, Mass. – Dec. 5, 2015 –The Multiple Myeloma Research Foundation (MMRF), a leader in accelerating the development of breakthrough multiple myeloma therapies, and GNS Healthcare (GNS), a leading precision medicine company that applies causal machine learning […]

GNS Healthcare CEO Colin Hill to Address AHIP Institute 2015 General Session

CAMBRIDGE, Mass. – May 26, 2015 – Precision medicine pioneer Colin Hill will be a featured speaker at AHIP Institute 2015, offering a real-world view of how precision medicine is converging with population health to enable truly individualized interventions and dramatically improve return on population health investments. Hill is chairman and CEO of GNS Healthcare, […]

MMRF, GNS Healthcare to Collaborate on CoMMpass Study

GNS Healthcare and the Multiple Myeloma Research Foundation announced today an agreement to use GNS’ informatics solutions to explore genomic and clinical data from the Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile, or CoMMpass, study. Read the complete article here…

The Multiple Myeloma Research Foundation and GNS Healthcare Announce Collaboration to Identify Potential New Multiple Myeloma Therapies

Initiative will deploy predictive big data analytics to analyze patient data from landmark CoMMpass Study™ to speed drug discovery and development for patients with multiple myeloma CAMBRIDGE, Mass. and NORWALK, Conn. – Jan. 7, 2015 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, and the […]

Scientific American Worldview and Center for Medicine in the Public Interest Honor GNS Healthcare CEO and Co-Founder Colin Hill

‘Top Medical Innovators’ Honor Recognizes GNS for Work in Multiple Myeloma CAMBRIDGE, Mass. – Dec. 9, 2014 – GNS Healthcare (GNS), a leading provider of analytics solutions for driving personalized interventions that improve population health, today announced that its CEO and co-founder, Colin Hill, has been honored by Scientific American Worldview as a Top Medical […]